Related Experiment Video
Updated: Jun 29, 2026

A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
Published on: April 24, 2012
Role of hERG potassium channel assays in drug development
Birgit T Priest1, Ian M Bell, Maria L Garcia
1Department of Ion Channels, Merck Research Laboratories, Rahway, New Jersey, USA. birgit_priest@merck.com
Insights
Screening drug candidates for hERG channel activity early is crucial. This prevents costly failures due to QT prolongation and potential cardiac arrhythmias, ensuring safer drug development.
Area of Science:
- Pharmacology
- Cardiology
- Drug Safety
Background:
- The hERG potassium channel is vital for cardiac repolarization.
- Drug-induced blockade of hERG channels can lead to QT prolongation and fatal arrhythmias.
- Early identification of hERG activity is essential to mitigate drug development risks.
Purpose of the Study:
- To highlight the importance of early screening for hERG channel activity in drug discovery.
- To discuss available methods for assessing hERG channel interactions.
- To guide efficient structure-function relationship development for hERG inhibitors.
Main Methods:
- Utilizing a range of assays, from high-throughput binding assays to detailed electrophysiological studies.
- Employing functional assays such as membrane potential or rubidium flux measurements.
- Integrating binding and functional assays with electrophysiology for comprehensive evaluation.
Main Results:
- hERG channel blockade by diverse drug classes is a significant safety concern.
- Early screening identifies compounds likely to cause QT prolongation.
- A combination of screening methods allows for efficient structure-activity relationship determination.
Conclusions:
- Early and thorough screening of drug candidates for hERG channel activity is paramount for preclinical safety.
- A tiered approach using various assays can optimize the identification of safe drug leads.
- Understanding hERG interactions early streamlines lead optimization and reduces late-stage attrition.
Abstract:
Numerous structurally and functionally unrelated drugs block the hERG potassium channel. HERG channels are involved in cardiac action potential repolarization, and reduced function of hERG lengthens ventricular action potentials, prolongs the QT interval in an electrocardiogram, and increases the risk for potentially fatal ventricular arrhythmias. In order to reduce the risk of investing resources in a drug candidate that fails preclinical safety studies because of QT prolongation, it is important to screen compounds for activity on hERG channels early in the lead optimization process. A number of hERG assays are available, ranging from high throughput binding assays on stably expressed recombinant channels to very time consuming electrophysiological examinations in cardiac myocytes. Depending on the number of compounds to be tested, binding assays or functional assays measuring membrane potential or Rb(+) flux, combined with electrophysiology on a few compounds, can be used to efficiently develop the structure-function relationship of hERG interactions.
Related Concept Videos
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
G-Protein Gated Ion Channels
Sensory organs,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

